新賽股份(600540.SH)受讓沙灣新賽100%股權
格隆匯5月20日丨新賽股份(600540.SH)公佈,為優化公司的管理架構,公司下屬全資子公司沙灣縣康瑞棉花加工有限責任公司(以下簡稱“沙灣康瑞”)已於近期將其持有的沙灣縣新賽棉業有限責任公司(以下簡稱“沙灣新賽”)100%股權全部轉讓給公司。近日沙灣新賽在沙灣縣市場監督管理局完成了工商變更登記備案。
本次轉讓前,沙灣新賽為沙灣康瑞的全資子公司,系公司全資孫公司,沙灣新賽註冊資本500萬元人民幣,沙灣康瑞持有其100%股權。本次股權轉讓完成後,沙灣新賽成為公司的全資子公司,註冊資本不變,公司持有其100%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.